Mostrar el registro sencillo del ítem
dc.contributor.author
Mastaglia, Silvina Rosana
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.date.available
2022-03-31T13:23:11Z
dc.date.issued
2020
dc.identifier.citation
Sequential treatment for idiopathic osteoporosis in premenopausal women: A case report; The Argentinian Society of Osteology and Mineral Metabolism Annual Meeting; Ciudad de Buenos Aires; Argentina; 2019; 2-2
dc.identifier.issn
2473-4039
dc.identifier.uri
http://hdl.handle.net/11336/154115
dc.description.abstract
Idiopathic osteoporosis (IOP) affects young, otherwise healthy individuals with intact gonadal function and no secondary cause for bone loss or fragility. IOP may be associated with major osteoporotic fractures such as low-trauma spine or hip. Aim: To evaluate the safety and effectiveness of sequential treatment in premenopausal women diagnosed with IOP. Case Presentation: A33-year-old premenopausal woman was referred by the Gynecology Department to evaluate bone and mineral metabolism.At 28 years of age, the patient had shown a fracture for bone fragility on her right hip. Attaining menarche at age 9, she had regular menstrual cycles (estradiol: 39.3pg/ml and follicle-stimulating hormone: 8.4mIU/l).At the time of consultation, she showed a bone mineral density (BMD, Hologic Equipment, Discovery Wi) in lumbar spine:0.720g/cm2; Z-score: -3.2, and in total left femur: 0.536g/cm2; Z-score: -3.3. No osteoporosis-provoking secondary causes were identified; thus, it was interpreted as IOP. She received sequential therapy (ST) with teriparatide(PTH1-34; Forteo; Eli Lilly&Co., Indianapolis, IN, USA) for two years, and then with densoumab 60mg s.c. (Prolia; Amgen Inc., California, CA, USA) associated with a calcium dietary supply of 1000mg/day and vitamin D3100.000IU/bi-monthly. Results: A 19% increase in LS BMD (least significant change [LSC]: 2.2%) and 16% in FIT (LSC: 3.0%) was observed. Conclusion: The ST was associated with large increase in BMD of LS and FIT in our patient. No adverse effects associated with teriparatide or denosumab were observed. Further clinical studies are necessary to determine the safety and effectiveness of ST in those premenopausal women withIOP. Until then, ST should be used with caution.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Wiley
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
OSTEOPOROSIS IDIOPATICA
dc.subject
TRATAMIENTO SECUENCIAL
dc.subject.classification
Endocrinología y Metabolismo
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Medicina Clínica
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
Sequential treatment for idiopathic osteoporosis in premenopausal women: A case report
dc.type
info:eu-repo/semantics/publishedVersion
dc.type
info:eu-repo/semantics/conferenceObject
dc.type
info:ar-repo/semantics/documento de conferencia
dc.date.updated
2022-03-16T19:47:06Z
dc.journal.volume
4
dc.journal.number
51
dc.journal.pagination
2-2
dc.journal.pais
Estados Unidos
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.journal.ciudad
Washington
dc.description.fil
Fil: Mastaglia, Silvina Rosana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10340
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/jbm4.10340
dc.conicet.rol
Autor
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.coverage
Nacional
dc.type.subtype
Reunión
dc.description.nombreEvento
The Argentinian Society of Osteology and Mineral Metabolism Annual Meeting
dc.date.evento
2019-10-30
dc.description.ciudadEvento
Ciudad de Buenos Aires
dc.description.paisEvento
Argentina
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.type.publicacion
Journal
dc.description.institucionOrganizadora
Asociación Argentina de Osteología y Metabolismo Mineral
dc.source.revista
Journal of the American Society for Bone and Mineral Research
dc.date.eventoHasta
2019-11-01
dc.type
Reunión
Archivos asociados